Teratogen update: antithyroid drugs—methimazole, carbimazole, and propylthiouracil
Open Access
- 4 January 2002
- journal article
- review article
- Published by Wiley in Teratology
- Vol. 65 (1) , 38-44
- https://doi.org/10.1002/tera.1096
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Effects of Propylthiouracil and Methimazole on Fetal Thyroid Status in Mothers with Graves' HyperthyroidismJournal of Clinical Endocrinology & Metabolism, 1997
- Methimazole and Propylthiouracil Equally Cross the Perfused Human Term Placental LobuleJournal of Clinical Endocrinology & Metabolism, 1997
- Assessment of Fetal Thyroid Function by Colored Doppler EchographyFetal Diagnosis and Therapy, 1997
- Aplasia cutis congenita after exposure to methimazole: a causal relationship?British Journal of Dermatology, 1995
- Review of Antithyroid Drug Use During Pregnancy and Report of a Case of Aplasia CutisThyroid®, 1994
- Intellectual capacity of subjects exposed to methimazole or propylthiouracil in uteroEuropean Journal of Pediatrics, 1992
- The Management of Thyrotoxicosis in PregnancyNew England Journal of Medicine, 1985
- Immunologic and Genetic Factors in Autoimmune DiseasesNew England Journal of Medicine, 1984
- Hyperthyroidism during PregnancyNew England Journal of Medicine, 1978
- Neonatal hypothyroidism and goiter in oneinfant of each of two sets of twins due to maternal therapy with antithyroid drugsThe Journal of Pediatrics, 1974